IP Library › Assignment 013653/0444
Patent Assignment
Reel/Frame 013653/0444

Assignment of Assignor's Interest

Recorded: 2003-01-14 Pages: 5
Assignor
Assignee
ROCHE HOLDINGS, INC.
1201 N. ORANGE STREET, SUITE 1050, WILMINGTON, DELAWARE, 19801
Covered Properties (36)
9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine as Antiviral Agent
Patent: 4,355,032 →
Application: 06/267,210 →
9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine as Antiviral Agent
Patent: 4,507,305 →
Application: 06/473,169 →
Process for Preparing 2,6-Substituted-9-(1,3-Dihydroxy-2- Propoxymethyl)-Purines and Certain Derivatives
Patent: 4,621,140 →
Application: 06/582,696 →
Acid Stabilized Composition of Thieno-Pyridine Derived Compounds
Patent: 4,591,592 →
Application: 06/665,675 →
1,3-Dibenzyloxy-2-Acetoxymethoxypropane, Intermediate for 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine
Patent: 4,603,219 →
Application: 06/666,584 →
Anhydrous Crystalline 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine
Patent: 4,642,346 →
Application: 06/747,631 →
Process for Preparing (+)-2,3-Dihydro-1H-Pyrrolo(1,2-a)Pyrrole-1,7- Dicarboxylates
Patent: 4,835,288 →
Application: 07/003,162 →
Morpholinoethylesters of Mycophenolic Acid and Pharmaceutical Compositions
Patent: 4,753,935 →
Application: 07/008,717 →
Process for Preparing (+)-2,3-Dihydro-1H-Pyrrolo(1,2-a) Pyrrole-1-Carboxylic Acid and Related Compounds
Patent: 4,874,871 →
Application: 07/030,774 →
Method of Preparing Long Acting Formulation
Patent: 4,940,556 →
Application: 07/057,469 →
Method of Treating Diseases by Administering Morpholinoethylester of Mycophenolic Acid and Derivatives Thereof
Patent: 4,808,592 →
Application: 07/093,459 →
Treatment of Allograft Rejection with Mycophenolic Acid Morpholino- Ethylester and Derivatives Thereof
Patent: 4,786,637 →
Application: 07/146,883 →
Alkoxy Methyl Ether and Alkoxy Methyl Ester Derivatives
Patent: 5,225,590 →
Application: 07/186,503 →
Treatment of Allograft Rejection with Mycophenolic Acid, Its Morpholinoethylester and Derivatives Thereof
Patent: 4,868,153 →
Application: 07/233,200 →
Method of Treating Diseases by Administering Morpholino-Ethylester of Mycophenolic Acid or Derivatives Theereof
Patent: 4,952,579 →
Application: 07/272,161 →
Process for Preparing (+)-2,3-Dihydro-1H-Pyrrolo(1,2-a)Pyrrole-1,7- Dicarboxylates
Patent: 4,937,368 →
Application: 07/299,701 →
Preservative System for Ophthalmic Formulations
Patent: 5,414,011 →
Application: 07/329,451 →
Treatment of Autoimmune Diseases with the Morpholinoethyl Ester of Mycophenlic Acid, and Derivatives Thereof
Patent: 4,948,793 →
Application: 07/373,413 →
Preparation of 2-(2'-Thienyl)Ethylamine Derivatives and Synthesis of Thieno(3,2-C)Pyridine Derivatives Therefrom
Patent: 5,068,360 →
Application: 07/470,299 →
Treatment of Autoimmune Diseases with Mycophenolic Acid, and Derivatives and Formulations Thereof
Patent: 4,992,467 →
Application: 07/500,439 →
Nicardipine Pharmaceutical Composition for Parenteral Administration
Patent: 5,164,405 →
Application: 07/600,277 →
Ophthalmic Nsaid Formulations Containing a Quaternary Ammonium Preservative and a Nonionic Surfactant
Patent: 5,110,493 →
Application: 07/624,027 →
N-2-Chlorobenzyl-2-Oxo and N-2-Chlorobenzyl-2,2-Dioxo-1,2,3- Oxathiazolidine Derivatives, Their Preparation and Synthesis of Thieno (3,2-C)Pyridine Derivatives Therefrom
Patent: 5,342,953 →
Application: 07/648,117 →
Preparation of 2-(2'-Thienyl)Ethylamine Derivatives and Synthesis of Thieno(3,2-C)Pyridine Derivatives Therefrom
Patent: 5,191,090 →
Application: 07/738,697 →
Long Acting Nicardipine Hydrochloride Formulation
Patent: 5,198,226 →
Application: 07/794,356 →
Direct Esterification of Mycophenolic Acid
Patent: 5,247,083 →
Application: 07/993,146 →
High Dose Formulations
Patent: 5,455,045 →
Application: 08/061,656 →
High Dose Ranolazine Formulations
Patent: 5,472,707 →
Application: 08/239,621 →
N-2-Chlorobenzyl-2-Oxo and N-2-Chlorobenzyl-2,2-Dioxo-1,2,3-Oxathiazolidine Derivatives, Their Preparation and Synthesis of Thieno[3,2-C]Pyridine Derivatives Therefrom
Patent: 5,516,910 →
Application: 08/245,789 →
Preparation of N-9 Substituted Guanine Compounds
Patent: 5,565,565 →
Application: 08/286,045 →
Crystalline Anhydrous Mycophenolate Mofetil and Intravenous Formulation Thereof
Patent: 5,543,408 →
Application: 08/349,236 →
Process for the Preparation of Enteric Coated Pharmaceutical Dosage Forms
Patent: 6,224,911 →
Application: 08/375,049 →
Mycophenolate Mofetil High Dose Oral Suspensions
Patent: 5,688,529 →
Application: 08/412,645 →
High Dose Formulations of Mycophenolate Mofetil and Mycophenolic Acid
Patent: 5,554,384 →
Application: 08/459,227 →
Process for Preparing Pharmaceutical Compositions Containing Crystalline Anhydrous Mycophenolate Mofetil Salts
Patent: 5,545,637 →
Application: 08/459,991 →
Sustained Release Poly (Lactic/Glycolic) Matrices
Patent: 5,759,583 →
Application: 08/560,081 →
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Sep 8, 1981
From: VERHEYDEN, JULIEN P.; MARTIN, JOHN C.
To: SYNTEX (U.S.A.) INC.
Reel/Frame 003905/0239 →
Assignment of 1/2 of Assignors Interest Apr 20, 1984
From: VERHEYDEN, JULIEN P. H.; MARTIN, JOHN C.
To: SYNTEX (U.S.A.) INC., A CORP. OF DE
Reel/Frame 004246/0598 →
Assignment of Assignors Interest. Sep 10, 1984
From: VERHEYDEN, JULIEN P. H.; MARTIN, JOHN C.; MCGEE, DANIEL P. C.
To: SYNTEX INC., A CORP OF DE
Reel/Frame 004299/0761 →
Assignment of Assignors Interest. Mar 7, 1985
From: CHOWHAN, ZAKA-UD-DIN T.
To: SYNTEX (U.S.A.) INC., A CORP OF DE
Reel/Frame 004369/0103 →
Assignment of Assignors Interest. Aug 12, 1985
From: CHAN, TAI W.; NGUYEN, HUONG T.
To: SYNTEX INC.
Reel/Frame 004439/0996 →
Assignment of Assignors Interest. Jun 25, 1987
From: FLEMING, MICHAEL P.; SCHLOEMER, GEORGE C.; KHATRI, HIRALAL N.
To: SYNTEX (U.S.A) INC., A CORP. OF DE.
Reel/Frame 004726/0815 →
Assignment of Assignors Interest. Jun 25, 1987
From: KHATRI, HIRALAL N.; FLEMING, MICHAEL P.; SCHLOEMER, GEORGE C.
To: SYNTEX (U.S.A.) INC., A CORP. OF DE
Reel/Frame 004726/0824 →
Assignment of Assignors Interest. Effective: January 29, 1987 Jul 16, 1987
From: NELSON, PETER H.; GU, CHEE-LIANG L.; ALLISON, ANTHONY C.; EUGUI, ELSIE M.
To: SYNTEX (U.S.A.) INC., 3401 HILLVIEW AVENUE, P.O. BOX 10850 PALO ALTO, CALIFORNIA 94303, A CORP. OF DE.
Reel/Frame 004737/0220 →
Assignment of Assignors Interest. Nov 14, 1988
From: ALLISON, ANTHONY C.; EUGUI, ELSIE M.; NELSON, PETER H.; GU, CHEE-LIANG LEO
To: SYNTEX (U.S.A.) INC., A CORP. OF DE
Reel/Frame 004982/0422 →
Assignment of Assignors Interest. May 15, 1989
From: FU, CHERNG-CHYI R.; LIDGATE, DEBORAH M.
To: SYNTEX (U.S.A.) INC., A CORP. OF DE.
Reel/Frame 005072/0715 →
Assigns the Entire Interest, Effective as of January 23, 1990. Aug 5, 1991
From: DEHOFF, BRADLEY S.
To: SYNTEX (U.S.A.) INC. A CORP. OF DELAWARE
Reel/Frame 005789/0253 →
Assignment of Assignor's Interest May 24, 1994
From: COOPER, GARY FRANCIS; MCCARTHY, KEITH EDWARD
To: SYNTEX (U.S.A.) INC.
Reel/Frame 007000/0641 →
Certificate of Merger Jan 18, 2001
From: SYNTEX (U.S.A.) INC.
To: SYNTEX (U.S.A.) LLC
Reel/Frame 011238/0699 →
Merger Jun 1, 2001
From: SYNTEX (U.S.A.)INC.
To: SYNTEX (U.S.A.) LLC
Reel/Frame 011846/0791 →
Assignment of Assignor's Interest Jan 14, 2003
From: ROCHE HOLDINGS, INC.
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 013653/0418 →
Assignment of Assignor's Interest May 23, 2005
From: HOFFMANN-LA ROCHE INC.
To: ROCHE PALO ALTO, LLC
Reel/Frame 016263/0717 →
Assignment of Assignor's Interest Nov 16, 2006
From: HOFFMANN-LA ROCHE INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 018524/0632 →
Merger Apr 5, 2007
From: SYNTEX (U.S.A.) INC.
To: SYNTEX (U.S.A.) LLC
Reel/Frame 019116/0508 →
Assignment of Assignor's Interest Apr 5, 2007
From: MACFARLANE, CALUM B.; SELKIRK, ALISTAIR B.; DEY, MICHAEL J.
To: SYNTEX (U.S.A.) INC.
Reel/Frame 019116/0504 →
Assignment of Assignor's Interest Jul 18, 2008
From: PDL BIOPHARMA, INC.
To: EKR THERAPEUTICS, INC.
Reel/Frame 021253/0306 →
To Correct an Error in a Cover Sheet Previously Re Nov 17, 2008
From: PDL BIOPHARMA, INC.
To: EKR THERAPEUTICS, INC.
Reel/Frame 021842/0719 →
Security Agreement Dec 15, 2008
From: EKR THERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021976/0780 →